Paul Ruddy is a digital transformation leader and the founder of Zyos Group. Over more than fifteen years he has founded four software and services companies — an IT managed services firm and two analytics software startups before Zyos Group — and owned the P&L at each. He has also served in dual‑hat C‑level operating roles at Central Jersey Blood Center and Next Level Performance. He advises, consults, and speaks with leaders on operational transformation and reliable agentic AI.
Paul Ruddy is the founder of Zyos Group, where he and his team work with associations, PE‑backed SMBs, and operations‑heavy organizations to diagnose operational maturity, prioritize with value‑stream and readiness scoring, and deploy agentic AI only after the underlying operations are ready for it.
Over the prior fifteen years he founded three software and services companies and owned the P&L at each: Zyos Technology, an IT managed services firm serving more than 100 enterprises; BI Analytics, a predictive and prescriptive analytics company building M&A diligence, production planning, and executive decision‑support systems for healthcare, manufacturing, distribution, and retail; and Blood‑Analytics, a BI SaaS for FDA‑regulated plasma and blood centers.
He has also held dual‑hat C‑level operating roles inside operations‑heavy companies — Director of IT then CIO/COO at Central Jersey Blood Center, and VP of IT & Operations at Next Level Performance. Through Zyos Group he currently serves a multi‑year fractional Chief Digital Officer engagement with Future Technologies Venture. Paul holds an MBA (MIS concentration) from Montclair State University and a B.S. in Management Information Systems from West Virginia University.
Paul Ruddy has spent the last fifteen‑plus years founding software and services companies and operating inside operations‑heavy businesses at the C level. He started in a global marketing services firm, building forecasting and inventory models for direct‑mail pharmaceutical fulfillment, then joined Central Jersey Blood Center — an FDA‑regulated blood center — where he climbed from systems manager to Chief Information Officer and Chief Operating Officer. There he built a data warehouse, introduced ITIL and a Project Management Office, brought agile and bimodal IT into a regulated environment, and led the FDA‑regulated donor management system conversion in six months — against a typical 13‑month timeline.
In 2010 he founded Zyos Technology, an IT managed services firm he built, sold into, staffed, and ran as the P&L owner; it grew to support more than 100 enterprises across New Jersey. In parallel he founded two analytics software startups: Blood‑Analytics, a BI SaaS for plasma and blood centers covering production planning, predictive analytics, and 510(k) compliance; and BI Analytics, a company shipping predictive and prescriptive analytics systems for M&A diligence, production planning, and executive decision support across healthcare, manufacturing, distribution, wholesale, and retail. He owned product, customer, and P&L at both.
From 2018 to 2021 Paul served as VP of IT & Operations at Next Level Performance, running software development, IT, security, marketing operations, and pricing across an enterprise SaaS business in the sales‑incentives space. In 2019 he founded Zyos Group — the synthesis of everything that came before — with a thesis that operational transformation must precede agentic AI. Zyos Group engagements have spanned associations, PE‑backed SMBs, and healthcare, including a multi‑year fractional Chief Digital Officer engagement with Future Technologies Venture beginning in 2022.
Paul advises, consults, and speaks with executives, boards, and operating partners on operational transformation, process intelligence, and the discipline behind reliable agentic AI. He holds an MBA (MIS concentration) from Montclair State University and a B.S. in Management Information Systems from West Virginia University. He lives in the Greater New York area.